Sowa-Rigpa medicines: safety, quality and interactions

This review gathers safety information that applies to traditional and herbal products, including those a Sowa-Rigpa practitioner may suggest. It draws on the World Health Organization (WHO), the Ministry of Ayush and the US National Institutes of Health. It makes no claim that any product works for any disease, and it gives no doses.

1. Introduction

The Ministry's introduction page says several medicines of Indian origin, such as Ashwagandha, Guggulu, Triphala, Ashok and Haridra, are used in Sowa-Rigpa ^[2]. Herbal products like these are widely sold. A common belief is that anything traditional is gentle and safe. Official sources are more careful than that.

2. What WHO says about safety

WHO says the safety of traditional medicine depends on practitioner competence, product quality, effective communication and strong regulatory support. It says adverse events, medication errors and quality problems can happen in any area of health care, and that when training, quality assurance and clear practice frameworks are in place, traditional medicine is usually a safe and trusted source of healing ^[1]. WHO also notes that monitoring product safety is a common challenge and encourages countries to set up pharmacovigilance systems that cover both conventional drugs and traditional products. Pharmacovigilance means collecting and studying reports of side effects ^[1]. It adds that establishing efficacy and safety through rigorous scientific validation is crucial, even for remedies used for a long time ^[1]. WHO has also published guidance on the quality of herbal medicines, including good manufacturing practices, quality control of herbal materials, contaminants and residues, and good agricultural and collection practices for medicinal plants ^[1]. It reports that 124 Member States have passed laws or regulations for herbal medicines ^[1].

3. Quality and standards in India

The Ministry's 2024 report says that establishing pharmacopoeial standards, meaning written quality standards for medicines, is essential for Ayurveda, Siddha, Unani and Homoeopathy medicines. It says the Government is working on developing them and that they are official for the drug testing provisions of the Drugs and Cosmetics Act, 1940 ^[3]. The passage does not name Sowa-Rigpa, so a patient cannot assume that a Sowa-Rigpa product has the same standard. The report also notes that medicinal plants raise issues such as sustainability, quality assurance and conservation, and that the National Medicinal Plants Board coordinates these matters ^[3]. Because the report says nothing about Sowa-Rigpa products in this passage, ask your doctor or pharmacist how to report a suspected side effect.

4. Natural does not always mean safe

NIH guidance on supplements is clear on several points ^{[4, 5]}:

• "Natural" does not always mean "safe". Kava and comfrey, for example, can cause serious liver harm ^{[4, 5]}.
• Labels such as "standardised", "verified" or "certified" do not guarantee quality or consistency ^{[4, 5]}.
• What is on the label may not match what is in the bottle ^[4].
• Some products, especially those sold for weight loss, sexual health or bodybuilding, have been found to contain hidden prescription drugs ^{[4, 5]}.
• In the United States, marketers do not have to show the FDA that a supplement is safe or effective before it is sold ^[5]. NIH says supplement rules are less strict than those for prescription and over-the-counter medicines, and the FDA can act against unsafe products only after they reach the market ^[4].
• A 2015 study estimated about 23,000 emergency room visits a year in the United States linked to supplements. Acute liver injury from supplements is rare but increasing, and can be severe ^[4].
• Supplements can interact with prescription and over-the-counter medicines and with each other. St. John's wort is given as an example that makes many medicines less effective ^{[4, 5]}.

These are statements about supplements in general and in the United States. They show the kinds of problems that can occur with any herbal product, including those sold in India.

5. Special groups

NIH notes that many supplements have not been tested in pregnant or breastfeeding people, in people trying to conceive or in children. Some supplements may raise bleeding risk or affect anaesthesia, so people having surgery should share their list in advance. Large vitamin pills have been linked to swallowing problems that needed emergency care ^[4]. If you are being treated for cancer or HIV, discuss every supplement with your doctor, because some can interfere with treatment ^[6].

6. Safer habits

• Ask the practitioner what the product contains, who made it and how long it has been used.
• Follow the label or the practitioner's instructions, and never take more because it seems harmless.
• Keep the packaging so your doctor or pharmacist can check the ingredients.
• If you notice a side effect, stop the product and contact your doctor ^[4].

7. When to see a doctor

See a doctor promptly for rash, swelling, vomiting, yellow eyes or skin, dark urine, severe stomach pain, unusual bleeding, palpitations or any reaction after starting a product. Pregnant or breastfeeding women and parents of children should ask a doctor before giving or taking any herbal product. In an emergency, call your local emergency number (112 in India, 911 in the United States).

8. Conclusion

WHO says safe traditional medicine rests on skilled practitioners, good products, open communication and regulation. In India the Ministry's report describes work on pharmacopoeial standards for several Ayush systems, but it does not name Sowa-Rigpa in the standards passage. NIH guidance shows that herbal products can be contaminated, mislabelled or interact with medicines. Ask questions, stop a product if you have a side effect, and tell your doctor.